Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ganser

Showing results (181-190 of 378) with videos related to

Pageof 38
Sort By:
Experimental Hematology|September 1, 1991
Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cellsO G Ottmann, C C Stella, M Eder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Metastatic malignant ameloblastoma responding to chemotherapy with paclitaxel and carboplatinV Grünwald, S Le Blanc, J H Karstens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Weekly administration of bendamustine: a phase I study in patients with advanced progressive solid tumoursP Schöffski, G Seeland, H Engel, et al.
AIDS Research and Human Retroviruses|April 1, 1992
Influence of human recombinant interferon-alpha and interferon-gamma on bone marrow progenitor cells of HIV-positive individualsR G Geissler, O G Ottmann, G Kojouharoff, et al.
Annals of Hematology|May 8, 2014
Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysisM Port, M Böttcher, F Thol, et al.
American Journal of Clinical Pathology|March 1, 1991
Bone marrow findings after treatment with recombinant human interleukin-3S Falk, G Seipelt, A Ganser, et al.
Bone Marrow Transplantation|November 13, 2001
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemiaL Hambach, M Eder, E Dammann, et al.
Annals of Hematology|February 11, 2018
Acquired long QT syndrome during conditioning for allogeneic stem cell transplantation-are we aware of this side effect?F Zauner, S Tayeb, V Panagiota, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Biologic effects of recombinant human interleukin-3 in vivoA Lindemann, A Ganser, F Herrmann, et al.
Scandinavian Journal of Gastroenterology|April 13, 2004
Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver diseaseF Tacke, P Schöffski, T Luedde, et al.
Pageof 38

Showing results (181-190 of 378) with videos related to

Sort By:
Pageof 38
Experimental Hematology|September 1, 1991
Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cellsO G Ottmann, C C Stella, M Eder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Metastatic malignant ameloblastoma responding to chemotherapy with paclitaxel and carboplatinV Grünwald, S Le Blanc, J H Karstens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Weekly administration of bendamustine: a phase I study in patients with advanced progressive solid tumoursP Schöffski, G Seeland, H Engel, et al.
AIDS Research and Human Retroviruses|April 1, 1992
Influence of human recombinant interferon-alpha and interferon-gamma on bone marrow progenitor cells of HIV-positive individualsR G Geissler, O G Ottmann, G Kojouharoff, et al.
Annals of Hematology|May 8, 2014
Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysisM Port, M Böttcher, F Thol, et al.
American Journal of Clinical Pathology|March 1, 1991
Bone marrow findings after treatment with recombinant human interleukin-3S Falk, G Seipelt, A Ganser, et al.
Bone Marrow Transplantation|November 13, 2001
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemiaL Hambach, M Eder, E Dammann, et al.
Annals of Hematology|February 11, 2018
Acquired long QT syndrome during conditioning for allogeneic stem cell transplantation-are we aware of this side effect?F Zauner, S Tayeb, V Panagiota, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Biologic effects of recombinant human interleukin-3 in vivoA Lindemann, A Ganser, F Herrmann, et al.
Scandinavian Journal of Gastroenterology|April 13, 2004
Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver diseaseF Tacke, P Schöffski, T Luedde, et al.
Pageof 38